Search results
Found 191 matches for
Acute myeloid leukaemia (AML) is a rare and often lethal form of blood cancer. Several groups at the WIMM focus on trying to understand how and why AML progresses, with the aim of developing better diagnostic and therapeutic strategies for this devastating disease.
Adam Wilkinson Wins Wellcome Career Development Award
MRC MHU RDM
17 April 2024
Associate Professor Adam Wilkinson has won an eight-year Wellcome Career Development Award to further his research.
Professor Graham Ogg Receives Wellcome Discovery Award with International Team
MRC TIDU RDM
16 April 2024
MRC TIDU Group Leader awarded funding for an international 8-year research programme from global charitable foundation Wellcome.
Novel pairing of integrins improves action of T cells on cancer cells to control tumour growth
CAMS Oxford Institute MRC TIDU NDM RDM
3 April 2024
New research published in Nature Immunology showcases the collaborative efforts of MRC TIDU researchers to describe a novel pairing of integrins which could improve T cell control of cancer.
Two Technician Champions appointed in the MRC WIMM
RDM
12 March 2024
We are delighted to announce that two members of the facilities staff at the MRC Weatherall Institute of Molecular Medicine have been chosen to act as Technician Champions.
MRC WIMM early career researchers present to Parliament
Centre for Computational Biology MRC MHU Paediatrics RDM
7 March 2024
Four members of the MRC Weatherall Institute of Molecular Medicine reached the final of STEM for Britain 2024, where they presented their research to Members of Parliament.
New study provides framework for optimising the design of antibody therapeutics
MRC TIDU NDM RDM
13 February 2024
World Cancer Day 2024: Highlighting Cancer Research at the MRC WIMM
Department of Oncology MRC MHU NDWRH Paediatrics RDM
4 February 2024
This World Cancer Day, we heard from four Group Leaders at the MRC Weatherall Institute of Molecular Medicine about their work and how their groups are helping in the fight against cancer.
Research into ancient DNA sheds new light on cause of Multiple Sclerosis and other neurodegenerative diseases
MRC TIDU NDCN RDM
11 January 2024
Researchers define new class of regulatory element in DNA
CAMS Oxford Institute NDM RDM
14 December 2023
MRC TIDU Spotlight Series: Koohy Group
Centre for Computational Biology MRC TIDU RDM TIDU Spotlight Series
16 November 2023
In the next instalment of the MRC TIDU Spotlight Series, we are highlighting the research of the Koohy Group.
Professor David Sims receives Major Educator Award
Centre for Computational Biology RDM
13 November 2023
Associate Professor David Sims has received the Major Educator Award as part of the 2023 Medical Sciences Division Teaching Excellence Awards
Single cell spatial analysis provides new insight into immune-pathology in Covid-19 lungs
CAMS Oxford Institute COVID-19 Centre for Computational Biology MRC TIDU NDM NIHR Oxford BRC RDM
9 November 2023
MRC TIDU Spotlight Series: Drakesmith Group
MRC TIDU RDM TIDU Spotlight Series
7 November 2023
In the fourth instalment in the MRC TIDU Spotlight Series, we take a look at the Drakesmith Group.
MRC TIDU Spotlight Series: Ho Group
MRC TIDU NDM RDM TIDU Spotlight Series
27 October 2023
In the next instalment of the MRC TIDU Spotlight Series, we are focusing on the Ho Group.
MRC TIDU Spotlight Series: Rehwinkel Group
MRC TIDU RDM TIDU Spotlight Series
20 October 2023
In this, the second instalment in the MRC TIDU Spotlight Series, we take a look at the Rehwinkel Group.
Emeritus Professor David Jackson receives Lifetime Achievement Awards
MRC HIU RDM
19 October 2023
Professor David Jackson has been awarded the Rooster Prize by the International Society for Hyaluronan Sciences (ISHAS) and the Gasparo Aselli Medal by the International Society of Lymphology (ISL).
MRC TIDU Spotlight Series: Ogg Group
MRC TIDU RDM TIDU Spotlight Series
12 October 2023
In this first instalment of the MRC TIDU Spotlight Series, we take a look at the Ogg Group - also known as the Translational Dermatology Unit.
Professor Simon Davis appointed as RDM’s first Entrepreneurship Lead
MRC TIDU RDM
5 October 2023
Simon Davis, Professor of Molecular Immunology in the MRC TIDU at the MRC WIMM, has been appointed as RDM’s first Entrepreneurship Lead.
MRC WIMM researchers contribute to “lipidomic map” offering insights into immunology
CAMS Oxford Institute MRC TIDU RDM
29 September 2023